TC Biopharm (Holdings) Plc
TCBPY
$0.3548
$0.039812.64%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -12.65% | -12.30% | -301.64% | -446.34% | -262.81% |
| Total Depreciation and Amortization | -33.31% | -33.50% | -24.29% | -26.67% | 14.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -57.14% |
| Total Other Non-Cash Items | -51.32% | -51.48% | 102.71% | 128.89% | 302.18% |
| Change in Net Operating Assets | -164.39% | -164.18% | -109.19% | -95.92% | 139.20% |
| Cash from Operations | -107.15% | -106.51% | 30.06% | 13.60% | 38.90% |
| Capital Expenditure | -191.03% | -190.55% | 45.66% | -- | 122.07% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 64.14% | 64.06% | 71.84% | 76.64% | 16.89% |
| Cash from Investing | -828.00% | -825.49% | 57.70% | 95.98% | 103.72% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 195.48% | 195.48% | 126,545.45% | -30.08% | 503.87% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -122.85% | -122.85% | -100.00% | -102.94% | -69.17% |
| Cash from Financing | 83.84% | 83.26% | 1,164.32% | -75.37% | -16.22% |
| Foreign Exchange rate Adjustments | 52.37% | 52.54% | -- | -- | -152.54% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -59.96% | -60.08% | 100.62% | -272.35% | 148.38% |